FertilityIQ DATA

Money, Occupation and IVF Success Rates

The number of women undergoing in vitro fertilization (IVF) treatment has grown more than 50% since the world financial crisis, and yet we as patients have little understanding about our individual prospects for success. We took a look at the data from our first thousand reviewers and were surprised by what we found. We thought we'd share with you some of what we presented at the 2016 American Society for Reproductive Medicine conference.

Wealthier Women Are More Likely To Have a Baby


Women with a household income of $100,000 are two times more likely to achieve success when undergoing IVF than women from households making under $100,000 (p < .05). This phenomenon persists after accounting for variables such as age, race, level of education and geography. It also applies to most other fertility treatments, not just IVF.

Despite the galloping pace at which hopeful parents are being treated, fertility treatment costs remain lofty: patients on FertilityIQ report, on average, paying $23,050 in drug and treatment costs per cycle. According to the CDC, the average IVF cycle is 70% likely to fail, thus forcing most patients to contemplate multiple rounds of therapy. For many, that is easier said than done, as the vast majority of respondents paid for their treatment out of pocket.

It would seem to make sense then that wealthier women are more successful because they can "throw money at the problem" and do more cycles, right? That's not what our data found. This disparity in success persisted even after we accounted for cycle volume. And we believe the same may be true for egg freezers as well.

Teacher & Sales Reps Do Best, Bankers & Engineers Do Worse


Women working in specific roles and fields fare significantly better than their peers when undergoing fertility treatment generally, and IVF specifically.

Teachers are nearly two times more likely to have success than their peers when undergoing IVF (p < .01), even after accounting for the pro-income bias mentioned above. Teachers tell us they feel their work environment puts them in a unique position to succeed: colleagues are happy to talk openly about their fertility experiences, are able to offer suggestions for better doctors, and teachers can use the summer months to undergo multiple cycles of treatment.

Similarly, we noticed women who work in roles in sales, marketing or public relations are more than twice as likely to record a successful outcome with IVF compared with women working in other roles (p < .05).

On the other hand, we note that women working in traditionally male-dominated roles (namely investment banking or engineering) were nearly 60% less likely to record success with their fertility treatments generally (p = .069), and IVF specifically. Often these women comment that their work environment represents a hindrance during treatment. Patients in these fields comment that they felt the need to keep their treatment a secret from bosses and colleagues and found it harder to begin, and adhere to, cycle requirements given competing work schedules and pressures.

We've also done extensive work to characterize which fields and employers provide the most generous fertility benefit packages. This November we released our 2016 Corporate Fertility Benefits Rankings.

Education is Potentially a Factor


While it’s an axiom within healthcare that patients with higher levels of education derive better outcomes in nearly all treatment classes, this was not the case for respondents here. We saw a gentle decline in cumulative rates of success with every incremental level of educational attainment. However, much of the significance washed away when we accounted for factors like age and income.

Similarly, we've seen patterns emerge of higher rates of success in the northeastern and western U.S., versus the southern and midwestern U.S., but the disparity doesn't meet statistical significance when we take into account a broader host of variables.

Expert's Perspective
The Male Fertility Evaluation: Enhances Options and Signals of Future Health
20 - 25% of U.S. couples annually undergo IVF without having the male partner properly checked. This drives tens of thousands of unnecssary treatments, as well as needless cost and suffering. What's more, bypassing this crucial step causes us to miss a vital signal into that man's future health.
Expert's Perspective
Is it safe to ship cryopreserved eggs (and embryos)?
Patients are increasingly eager to ship their eggs and embryos to clinics out of town, out of state and out of the country. Vitrification has made that a far more delicate process. Peter Nagy, Ph.D helps explain the outcomes, steps and costs associated with shipping gametes from one clinic to another.
Expert's Perspective
Freeze Eggs or Embryos?
When the option to freeze embryos is available to patients, many disregard the option to freeze eggs. Owen Davis, ASRM President, weighs in on why egg freezing is still an important option to consider.
Expert's Perspective
From MacBooks to MAC Cosmetics: How Our Daily Routine Impacts Fertility
Dr. Cooper lays out the evidence on the products & habits that harm fertility, and realistic steps we can take to protect ourselves
Expert's Perspective
Improving IVF Success Rates: Using Low Oxygen in the Lab
Selecting a clinic is as much about selecting their laboratory as anything else. A key determinant of lab quality is the conditions they use to culture embryos. Using low oxygen in the incubator is preferable, yet a third of laboratories don't do this.
Expert's Perspective
Early Pregnancy Loss
Early pregnancy loss is the only focus of the team at Montefiore-Einstein in NYC. Here are some of their high-level observations on how to deal with the medical challenges.
+ Show More Articles
Personal Story
Why I Didn't Choose Reproductive Immunology After Miscarriage
After undergoing IVF for secondary infertility, Elissa was blindsided by a miscarriage of a PGS-tested normal embryo. She kept reading online about immunological causes and treatments, so she used her background in reporting to get to the bottom of the treatments behind the chatroom hype.
Personal Story
What We Never Expected About Reciprocal IVF
Christina and her wife Katie decided to bulid their family using Reciprocal IVF. Christina walks us through what turned out how they expected, and what didn't -- including the financial costs, choosing sperm donors, IVF success (and failure), recognition by the state, and having the outside world accept them as equal mothers.
Personal Story
Getting it Together After the Diagnosis: Making a Plan With Your Partner
Laura and her wife Sam always presumed they would need treatment to have a child, but the news Laura had fertility issues came as a surprise. Over the course of multiple cycles, and multiple years, they learned a number of crucial lessons.
Personal Story
Marriage & Male Infertility: Not on the Same Page and That’s O.K.
Men and women often deal differently with the emotional impact of infertility. How important is it for us to see everything the same way?
Personal Story
Twiblings: Being Pregnant During Surrogacy
Some hopeful mothers fear that having a child through surrogacy will be less special or intimate. For those who wonder, meet Nancy Rohde, who carried her own child, and had a baby through surrogacy, at the same time.
Personal Story
Wrangling With Reduction
Many patients undergoing fertility treatment ultimately need to grapple with the notion of whether it is safe to have a multiple pregnancy. Katie Ferraro talks about her decision not to selectively reduce during her quadruplet pregnancy.
+ Show More Articles